FORA Capital’s Myriad Genetics MYGN Stock Holding History

FORA Capital’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,027	Closed	-$31K	–	683
2021 Q2	$31K	Buy	+1,027	New	+$29.7K	0.01%	778
2021 Q1	–	Sell	-7,261	Closed	-$144K	–	980
2020 Q4	$144K	Buy	7,261 +315	+5%	+$5.09K	0.02%	580
2020 Q3	$91K	Buy	+6,946	New	+$87.9K	0.06%	316

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

FORA Capital's MYGN Position: Q3 2021 in Review

FORA Capital sold out of Myriad Genetics (MYGN) in Q3 2021, closing a stake of 1,027 shares — an estimated $31K sold.

FORA Capital first reported a position in MYGN in Q3 2020 and held it in 3 quarters. The position peaked at $144K in Q4 2020. 213 funds tracked by Wall St. Rank hold MYGN as of Q3 2021.

FORA Capital reported no remaining Myriad Genetics position as of Q3 2021 after selling out during the quarter.
FORA Capital sold 1,027 Myriad Genetics shares in Q3 2021, an estimated $31K.
FORA Capital first reported a position in Myriad Genetics in Q3 2020 and held it in 3 quarters.
FORA Capital's Myriad Genetics position peaked at $144K in Q4 2020.
213 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.